In the 1980s, CSIRO and its university collaborators set into motion a chain of events that would lead to the production of relenza, the first drug to successfully treat the flu.
The danger of reporting findings before peer review is that scientists often can’t talk about the details of their research, which can lead to hype or fear in the media. A recent example of this is a controversial…